Literature DB >> 19680589

Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians.

F-Y Deng1, L-J Zhao, Y-F Pei, B-Y Sha, X-G Liu, H Yan, L Wang, T-L Yang, R R Recker, C J Papasian, H-W Deng.   

Abstract

UNLABELLED: Osteoporotic fracture (OF) is a serious outcome of osteoporosis. Important risk factors for OF include reduced bone mineral density and unstable bone structure. This genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians.
INTRODUCTION: Bone mineral density (BMD) and femoral neck cross-sectional geometric parameters (FNCSGPs) are under strong genetic control. DNA copy number variation (CNV) is an important source of genetic diversity for human diseases. This study aims to identify CNVs associated with BMD and FNCSGPs.
METHODS: Genome-wide CNV association analyses were conducted in 1,000 unrelated Caucasian subjects for BMD at the spine, hip, femoral neck, and for three FNCSGPs -cortical thickness (CT), cross-section area (CSA), and buckling ratio (BR). BMD was measured by dual energy X-ray absorptiometry (DEXA). CT, CSA, and BR were estimated using DEXA measurements. Affymetrix 500K arrays and copy number analysis tool was used to identify CNVs.
RESULTS: A CNV in VPS13B gene was significantly associated with spine, hip and FN BMDs, and CT, CSA, and BR (p < 0.05). Compared to subjects with two copies of the CNV, carriers of one copy had an average of 14.6%, 12.4%, and 13.6% higher spine, hip, and FN BMD, 20.0% thicker CT, 10.6% larger CSA, and 12.4% lower BR. Thus, a decrease of the CNV consistently produced stronger bone, thereby reducing osteoporotic fracture risk.
CONCLUSIONS: VPS13B gene, via affecting BMD and FNCSGPs, is a novel osteoporosis risk gene.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19680589     DOI: 10.1007/s00198-009-0998-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  41 in total

Review 1.  Cohen syndrome: essential features, natural history, and heterogeneity.

Authors:  S Kivitie-Kallio; R Norio
Journal:  Am J Med Genet       Date:  2001-08-01

2.  Genomic control for association studies.

Authors:  B Devlin; K Roeder
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

3.  Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport.

Authors:  Juha Kolehmainen; Graeme C M Black; Anne Saarinen; Kate Chandler; Jill Clayton-Smith; Ann-Liz Träskelin; Rahat Perveen; Satu Kivitie-Kallio; Reijo Norio; Mette Warburg; Jean-Pierre Fryns; Albert de la Chapelle; Anna-Elina Lehesjoki
Journal:  Am J Hum Genet       Date:  2003-05-02       Impact factor: 11.025

4.  Dynamic model based algorithms for screening and genotyping over 100 K SNPs on oligonucleotide microarrays.

Authors:  Xiaojun Di; Hajime Matsuzaki; Teresa A Webster; Earl Hubbell; Guoying Liu; Shoulian Dong; Dan Bartell; Jing Huang; Richard Chiles; Geoffrey Yang; Mei-mei Shen; David Kulp; Giulia C Kennedy; Rui Mei; Keith W Jones; Simon Cawley
Journal:  Bioinformatics       Date:  2005-01-18       Impact factor: 6.937

Review 5.  Structural variation in the human genome.

Authors:  Lars Feuk; Andrew R Carson; Stephen W Scherer
Journal:  Nat Rev Genet       Date:  2006-02       Impact factor: 53.242

6.  The genetics of proximal femur geometry, distribution of bone mass and bone mineral density.

Authors:  C W Slemenda; C H Turner; M Peacock; J C Christian; J Sorbel; S L Hui; C C Johnston
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

7.  Effects of current and discontinued estrogen replacement therapy on hip structural geometry: the study of osteoporotic fractures.

Authors:  T J Beck; K L Stone; T L Oreskovic; M C Hochberg; M C Nevitt; H K Genant; S R Cummings
Journal:  J Bone Miner Res       Date:  2001-11       Impact factor: 6.741

Review 8.  Bone strength and its determinants.

Authors:  P Ammann; R Rizzoli
Journal:  Osteoporos Int       Date:  2003-03-19       Impact factor: 4.507

9.  Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation.

Authors:  N F Ray; J K Chan; M Thamer; L J Melton
Journal:  J Bone Miner Res       Date:  1997-01       Impact factor: 6.741

10.  Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans.

Authors:  Timothy J Aitman; Rong Dong; Timothy J Vyse; Penny J Norsworthy; Michelle D Johnson; Jennifer Smith; Jonathan Mangion; Cheri Roberton-Lowe; Amy J Marshall; Enrico Petretto; Matthew D Hodges; Gurjeet Bhangal; Sheetal G Patel; Kelly Sheehan-Rooney; Mark Duda; Paul R Cook; David J Evans; Jan Domin; Jonathan Flint; Joseph J Boyle; Charles D Pusey; H Terence Cook
Journal:  Nature       Date:  2006-02-16       Impact factor: 49.962

View more
  17 in total

Review 1.  A look behind the scenes: the risk and pathogenesis of primary osteoporosis.

Authors:  Gretl Hendrickx; Eveline Boudin; Wim Van Hul
Journal:  Nat Rev Rheumatol       Date:  2015-04-21       Impact factor: 20.543

Review 2.  The genetics of bone loss: challenges and prospects.

Authors:  Braxton D Mitchell; Laura M Yerges-Armstrong
Journal:  J Clin Endocrinol Metab       Date:  2011-02-23       Impact factor: 5.958

3.  Exome sequencing-based copy-number variation and loss of heterozygosity detection: ExomeCNV.

Authors:  Jarupon Fah Sathirapongsasuti; Hane Lee; Basil A J Horst; Georg Brunner; Alistair J Cochran; Scott Binder; John Quackenbush; Stanley F Nelson
Journal:  Bioinformatics       Date:  2011-08-09       Impact factor: 6.937

Review 4.  Clinical review: Genome-wide association studies of skeletal phenotypes: what we have learned and where we are headed.

Authors:  Yi-Hsiang Hsu; Douglas P Kiel
Journal:  J Clin Endocrinol Metab       Date:  2012-09-10       Impact factor: 5.958

5.  Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics.

Authors:  Mohan Liu; Paul E Goss; James N Ingle; Michiaki Kubo; Yoichi Furukawa; Anthony Batzler; Gregory D Jenkins; Erin E Carlson; Yusuke Nakamura; Daniel J Schaid; Judy-Anne W Chapman; Lois E Shepherd; Matthew J Ellis; Sundeep Khosla; Liewei Wang; Richard M Weinshilboum
Journal:  Mol Endocrinol       Date:  2014-08-22

6.  CONAN: copy number variation analysis software for genome-wide association studies.

Authors:  Lukas Forer; Sebastian Schönherr; Hansi Weissensteiner; Florian Haider; Thomas Kluckner; Christian Gieger; Heinz-Erich Wichmann; Günther Specht; Florian Kronenberg; Anita Kloss-Brandstätter
Journal:  BMC Bioinformatics       Date:  2010-06-14       Impact factor: 3.169

7.  Runs of homozygosity identify a recessive locus 12q21.31 for human adult height.

Authors:  Tie-Lin Yang; Yan Guo; Li-Shu Zhang; Qing Tian; Han Yan; Christopher J Papasian; Robert R Recker; Hong-Wen Deng
Journal:  J Clin Endocrinol Metab       Date:  2010-05-13       Impact factor: 5.958

8.  Genome-wide copy number variation association analyses for age at menarche.

Authors:  Yao-Zhong Liu; Jian Li; Rong Pan; Hui Shen; Qing Tian; Yu Zhou; Yong-Jun Liu; Hong-Wen Deng
Journal:  J Clin Endocrinol Metab       Date:  2012-08-17       Impact factor: 5.958

9.  Future of osteoporosis genetics: enhancing genome-wide association studies.

Authors:  Charles R Farber; Aldons J Lusis
Journal:  J Bone Miner Res       Date:  2009-12       Impact factor: 6.741

Review 10.  Tyrosine hydroxylase gene: another piece of the genetic puzzle of Parkinson's disease.

Authors:  Guney Bademci; Jeffery M Vance; Liyong Wang
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-06-01       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.